Companies research board

Displaying 1101 - 1172 of 1172

A global medical affairs and research organization that helps biopharmaceutical and medical device manufacturers


Developer of a novel vaccine delivery platform that has applications across a wide range of diseases.


Vaccine company developing various vaccines using its proprietary non-invasive technology platform.


A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases.


A biotechnology company, engages in the formulation, development, and delivery of vaccines in the United States and internationally.


Drug formulations and devices for respiratory diseases. IPO in July 2004.


Developing innovative solutions for vascular disease using the principles of biomimicry.


Developing novel radiofrequency balloon catheter technology.


Dedicated to the development of novel antibody domains engineered to be stable in the GI tract.


Provides cord-blood banking and explores the potential in its therapeutical uses


A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders.


A biotechnology company discovering and developing innovative products that will transform the prevention and treatment of infectious diseases.


Biotechnology company focused on developing an artificial liver that would be used until a transplant is performed.


Developing novel genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza.


Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.


Vybion is a development stage company with a novel human antibody-based drug discovery platform.


Driving the Reemergence of Natural Products in the Era of Genomics


UK-based polymer specialist company developing and manufacturing novel functional polymers for high value applications


Discover and develop Medical Foods for inflammation-based diseases using natural products that are safe


Preclinical laboratory services


Primary manufacturer of biochemicals and enzymes.


A Contract Research Organization Supporting Enhanced Clinical Research in Early Drug Development


Provider of protein engineering technology platforms in the biotechnology industry.


Monoclonal antibody and small molecule therapeutics for Hepatitis. IPO in September 2000. Fully disposed.


Developing a proprietary gel formulation of mechlorethamine hydrochloride


A biotechnology company, engages in the development and marketing of oncology drugs to target glycans.


The world’s first biopharmaceutical company dedicated to developing novel obesity therapeutics.


Multi-asset clinical-stage biotechnology company focused on developing medicines for immune and inflammatory disorders.